AcelRx Pharmaceuticals, Inc. Short Interest Up 19.7 percent in July
| ACRXDelisted Stock | USD 1.01 0.01 1.00% |
Slightly above 50% of AcelRx Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in AcelRx Pharmaceuticals suggests that some traders are interested regarding AcelRx Pharmaceuticals' prospects. AcelRx Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, AcelRx Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
AcelRx |
AcelRx Pharmaceuticals, Inc. was the target of a large growth in short interest in July. As of July 31st, there was short interest totalling 1,030,000 shares, a growth of 19.7 percent from the July 15th total of 860,800 shares. Approximately 6.6 percent of the shares of the company are short sold. Based
Read at thelincolnianonline.com
 |
AcelRx Pharmaceuticals Fundamental Analysis
We analyze AcelRx Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AcelRx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AcelRx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
AcelRx Pharmaceuticals is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
AcelRx Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AcelRx Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of AcelRx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing AcelRx Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
AcelRx Pharmaceuticals Related Equities
| ASRT | Assertio Therapeutics | 4.06 | ||||
| LFCR | Lifecore Biomedical | 2.93 | ||||
| AMRX | Amneal Pharmaceuticals, | 1.29 | ||||
| TLRY | Tilray | 0.88 | ||||
| ORGO | Organogenesis Holdings | 0.85 | ||||
| AQST | Aquestive Therapeutics | 1.60 | ||||
| EVOK | Evoke Pharma | 2.65 | ||||
| SHPH | Shuttle Pharmaceuticals | 3.60 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in AcelRx Stock
If you are still planning to invest in AcelRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AcelRx Pharmaceuticals' history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |